Abstract
Cerebral malaria is a leading cause of global morbidity and mortality. Interventions targeting the underlying pathophysiology of cerebralmalaria may improve outcomes compared to treatment with antimalarials alone.Microvascular leak plays an important role in the pathogenesis of cerebral malaria. The angiopoietin (Ang)-Tie-2 system is a critical regulator of vascular function. We show that Ang-1 expression and soluble Tie-2 expression were associated with disease severity and outcome in a prospective study of Ugandan children with severe malaria and in a preclinical murine model of experimental cerebral malaria. Ang-1 was necessary for maintenance of vascular integrity and survival in a mousemodel of cerebralmalaria. Therapeutic administration of Ang-1 preserved blood-brain barrier integrity and, in combination with artesunate treatment, improved survival beyond that with artesunate alone. These data define a role for dysregulation of the Ang-Tie-2 axis in the pathogenesis of cerebral malaria and support the evaluation of Ang-Tie-2-based interventions as potential adjunctive therapies for treating severe malaria.
Original language | English (US) |
---|---|
Article number | 358ra127 |
Journal | Science translational medicine |
Volume | 8 |
Issue number | 358 |
DOIs | |
State | Published - Sep 28 2016 |
Funding
This work was supported by the Canadian Institutes of Health Research (CIHR) grants MOP-13721, MOP-115160, and MOP-136813, a CIHR Foundation grant (K.C.K.), the Canada Research Chairs Program (K.C.K. and W.C.L.), a CIHR Graduate Scholarship (S.J.H.), and donations from Kim Kertland and the Tesari Foundation.
ASJC Scopus subject areas
- General Medicine